tiprankstipranks
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market
SION
Sionna Therapeutics, Inc.
RESEARCH TOOLSreports

Sionna Therapeutics, Inc. (SION) Income Statement

26 Followers

Sionna Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Sionna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Sionna Therapeutics, Inc.'s net income was $-20.44M. See Sionna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -647.00K$ -668.00K$ 0.00$ 0.00
Operating Expenses
$ 88.33M$ 69.89M$ 50.33M$ 41.37M
Depreciation and Amortization
$ 647.00K$ 668.00K$ 583.00K$ 122.00K
EBITDA
$ -88.33M$ -69.89M$ -49.75M$ -41.25M
Operating Income
$ -88.98M$ -70.56M$ -50.33M$ -41.37M
Other Income/Expenses
$ 13.71M$ 8.87M$ 3.07M$ 1.13M
Pretax Income
$ -75.27M$ -61.69M$ -47.26M$ -40.24M
Net Income
$ -75.27M$ -61.69M$ -47.26M$ -40.24M
Per Share Metrics
Basic EPS
$ -1.88$ -1.40$ -1.07$ -0.91
Diluted EPS
$ -1.88$ -1.40$ -1.07$ -0.91
Weighted Average Shares Outstanding
 39.96M 44.12M 44.12M 44.12M
Weighted Average Shares Outstanding (Diluted)
 39.96M 44.12M 44.12M 44.12M
Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History